Despite curcumin demonstrating potential in the treatment of LN due to its anti-inflammatory and antioxidant properties and preliminary studies confirming its ability to inhibit neutrophil migration through the regulation of the AKT/NF-κB pathway—thereby positively intervening in the disease—its transition to widespread clinical use still faces significant hurdles. The gene discussed is NFKB1; the disease is lobular neoplasia.